BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10475983)

  • 1. A comparative review of conventional and lipid formulations of amphotericin B.
    Robinson RF; Nahata MC
    J Clin Pharm Ther; 1999 Aug; 24(4):249-57. PubMed ID: 10475983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid formulations of amphotericin B.
    Herbrecht R; Natarajan-Amé S; Nivoix Y; Letscher-Bru V
    Expert Opin Pharmacother; 2003 Aug; 4(8):1277-87. PubMed ID: 12877636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
    Tiphine M; Letscher-Bru V; Herbrecht R
    Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the lipid formulations of amphotericin B.
    Dupont B
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():31-6. PubMed ID: 11801578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid formulations of amphotericin].
    Botero MC; Puentes-Herrera M; Cortés JA
    Rev Chilena Infectol; 2014 Oct; 31(5):518-27. PubMed ID: 25491449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid formulations of amphotericin B.
    Dix SP; Andriole VT
    Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of amphotericin B lipid complex in managing systemic fungal infections.
    Chu P; Sadullah S
    Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
    Azanza JR; Sádada B; Reis J
    Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based formulations of amphotericin B.
    Veerareddy PR; Vobalaboina V
    Drugs Today (Barc); 2004 Feb; 40(2):133-45. PubMed ID: 15045035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid formulations of amphotericin B in the management of invasive fungal infections].
    Fohrer C; Nivoix Y; Moulin JC; Marçais A; Herbrecht R
    Therapie; 2006; 61(3):235-42. PubMed ID: 16989124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B lipid complex for the treatment of invasive fungal infections.
    Linden PK
    Expert Opin Pharmacother; 2003 Nov; 4(11):2099-110. PubMed ID: 14596663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid formulations of amphotericin B: clinical efficacy and toxicities.
    Wong-Beringer A; Jacobs RA; Guglielmo BJ
    Clin Infect Dis; 1998 Sep; 27(3):603-18. PubMed ID: 9770163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: a review.
    Viscoli C; Castagnola E
    Int J Infect Dis; 1998-1999 Winter; 3(2):109-18. PubMed ID: 10225990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B use in children: conventional and lipid-based formulations.
    Kuyucu N
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):357-67. PubMed ID: 21417875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amphotericin B and its lipid formulations].
    Ritter J
    Mycoses; 2002; 45 Suppl 3():34-8. PubMed ID: 12690969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.